The Access Consortium remains focused on enhancing cooperation amongst member countries to streamline procedures and improve access to safe and effective medicines. The aim is to create an environment that benefits patients, industry partners, and regulatory bodies alike.
The renewed plan emphasises solidifying collaborative processes, aligning expectations with industry, and improving communication strategies. The consortium is introducing a new cloud-based workspace to facilitate joint reviews, which will enhance the efficiency.
The key strategic objectives are:
- Strengthening work-sharing initiatives
- Expanding our lifecycle approach
- Supporting regulatory innovation
- Enhancing stakeholder engagement
The Access Consortium continues to encourage joint applications, particularly those involving all member countries, as these offer the greatest collaborative benefits.
For more information, please visit the newly launched Access webpage: